GWAS |
- Asthma ( 31619474)
- Body mass index ( 26426971)
- Glycine levels ( 30837465)
- HDL cholesterol ( 30275531)
- HDL cholesterol levels ( 30698716)
- HDL cholesterol levels in current drinkers ( 30698716)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Hip circumference adjusted for BMI ( 34021172)
- LDL cholesterol levels ( 30698716)
- LDL cholesterol levels in current drinkers ( 30698716)
- LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Multiple sclerosis ( 22190364)
- Optic cup area ( 25631615)
- Simvastatin-induced myopathy ( 31220337)
- Total cholesterol levels ( 33339817)
- Triglyceride levels ( 30698716)
- Triglyceride levels in current drinkers ( 30698716)
- Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- Very long-chain saturated fatty acid levels (fatty acid 20:0) ( 25378659)
|
- Autism spectrum disorder or schizophrenia ( 28540026)
- Bipolar disorder ( 31043756)
- Bipolar I disorder ( 31043756)
- Intraocular pressure ( 31959993)
- Normal facial asymmetry (deformation magnitude) ( 30631343)
- Response to radiotherapy in prostate cancer (toxicity, urinary frequency) ( 27515689)
- Schizophrenia ( 25056061)
|